Strand, Trovagene enter MOU to license and validate HPV assay technology
00:34 EDT 8 Jun 2012 | The Medical News
Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV..
Original Article: Strand, Trovagene enter MOU to license and validate HPV assay technology
More From BioPortfolio on "Strand, Trovagene enter MOU to license and validate HPV assay technology"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
